Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.

Healthy Subjects Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00180024
• Other study ID #: IKPD 01-02
• Status: Completed
• Phase: N/A
• First received: September 9, 2005
• Last updated: September 9, 2005
• Start date: January 2002
• Est. completion date: September 2005

Study information

• Verified date: September 2005
• Source: Technische Universität Dresden
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Federal Institute for Drugs and Medical Devices
• Study type: Interventional

Clinical Trial Summary

The hypothesis is tested that stimulation with angiotensin II after blockade of the AT1-receptor results in venodilation in human healthy subjects in vivo.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: September 2005
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• healthy subjects

Exclusion Criteria:

• any relevant disease

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Educational/Counseling/Training

Related Conditions & MeSH terms

• Healthy Subjects

Intervention

Drug:
• irbesartan (drug)

Locations

Country	Name	City	State
Germany	Institute of Clinical Pharmacology, Medical Faculty, University of Technology	Dresden

Sponsors (1)

Lead Sponsor	Collaborator
Technische Universität Dresden

Country where clinical trial is conducted

Germany,